As OpenAI gears up for a potential IPO, it's outlined a more tempered infrastructure strategy and has moved away from an ambitious agreement with Nvidia.
Discover how the construction market is responding to the surge in data centre demand and the innovative strategies brokers ...
Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ...
18hon MSN
From satellites to space data centers: Why low earth orbit is attracting billions in investment
Big Tech companies including Nvidia and Elon Musk's SpaceX are making large bets on a new layer of critical infrastructure ...
Document database pipelines may be being affected by schema drift: a guide for developers and DBAs from 3T Software Labs' ...
To scale AIoT data management, organizations must transition from fragmented pipelines to governed data orchestration, leveraging platforms like IoT83's Flex83 to unify industrial and enterprise ...
Integrating AI into chip workflows is pushing companies to overhaul their data management strategies, shifting from passive storage to active, structured, and machine-readable systems. As training and ...
Microscopic images of human tissue are a cornerstone of biomedical research and clinical diagnostics. Yet despite their importance, these images often remain difficult to analyze systematically and to ...
The Peasants’ Revolt of 1381 was one of the largest and most dramatic popular uprisings in medieval Europe. But what do we really know about this celebrated event in English history? The rising was ...
A new collaboration between EMBL's European Bioinformatics Institute (EMBL-EBI), Google DeepMind, NVIDIA, and Seoul National University has made millions of AI-predicted protein complex structures ...
According to Nvidia's press materials, DLSS 5 enhances lighting and material interactions without modifying underlying geometry. The company later reiterated this point to HotHardware, while TechSpot ...
Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong cash runway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results